Ticker Scorecard - KZR Basics Company: Kezar Life Sciences, Inc. IPO Date: June 18, 2018 Sector: Healthcare Industry: Biotech Market Cap: $47.86M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.35% Avg Daily Range (30 D): $0.15 | 2.26% Avg Daily Range (90 D): $0.10 | 2.28% Institutional Daily Volume Avg Daily Volume: .05M Avg Daily Volume (30 D): .05M Avg Daily Volume (90 D): .07M Trade Size Avg Trade Size (Sh.): 13 Avg Trade Size (Sh.) (30 D): 105 Avg Trade Size (Sh.) (90 D): 15 Institutional Trades Total Inst.Trades: 548 Avg Inst. Trade: $1.76M Avg Inst. Trade (30 D): $.69M Avg Inst. Trade (90 D): $.69M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.61M Avg Closing Trade (30 D): $4.17M Avg Closing Trade (90 D): $4.17M Avg Closing Volume: 23.01K     News Oct 5, 2023 @ 3:00 PM Benzinga's Top Ratings Upgrades, Downgrades For Oc... Source: Benzinga Insights Oct 4, 2023 @ 1:32 PM Kezar (KZR) Falls 10% on Strategic Update, Reduces... Source: Zacks Equity Research Sep 21, 2023 @ 11:51 AM Why Murphy Canyon Acquisition Shares Are Trading H... Source: Lisa Levin Sep 21, 2023 @ 10:48 AM The economy is about to slow down. That's the time... Source: MarketWatch Aug 21, 2023 @ 11:32 AM Top 5 Health Care Stocks That Could Blast Off This... Source: Lisa Levin Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.52 $-2.78 $-.3 Diluted EPS $-.52 $-2.78 $-.3 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -95.78M $ -20.31M $ -21.55M Operating Income / Loss $ -103.63M $ -21.95M $ -23.38M Cost of Revenue $ $ $ Net Cash Flow $ 8.36M $ 6.58M $ -7.22M PE Ratio     Splits Oct 30, 2024:   10:1